Haemonetics Newsroom

Haemonetics Is Maintained at Outperform by Barrington Research

Dow JonesSep 23 11:03 ET

Barrington Maintains Haemonetics(HAE.US) With Buy Rating, Maintains Target Price $108

Moomoo NewsSep 23 09:32 ET

Buy Rating Affirmed for Haemonetics With Promising Growth in Hospital Segment and Strong Plasma Market Position

TipRanksSep 23 09:22 ET

Haemonetics Analyst Ratings

BenzingaSep 13 15:36 ET

C.L. King Initiates Haemonetics(HAE.US) With Buy Rating, Announces Target Price $116

Moomoo NewsSep 13 09:32 ET

BofA Securities Initiates Haemonetics(HAE.US) With Hold Rating, Announces Target Price $85

Moomoo NewsSep 11 07:33 ET

Haemonetics Price Target Announced at $85.00/Share by B of A Securities

Dow JonesSep 11 07:20 ET

BTIG Initiates Haemonetics(HAE.US) With Buy Rating, Announces Target Price $112

Moomoo NewsSep 10 06:31 ET

Haemonetics Analyst Ratings

BenzingaAug 22 11:45 ET

Citi Maintains Haemonetics(HAE.US) With Hold Rating, Cuts Target Price to $85

Moomoo NewsAug 22 06:33 ET

Haemonetics Analyst Ratings

BenzingaAug 13 14:42 ET

Haemonetics Corporation: Strong Growth and Innovation Justify a Buy Rating

TipRanksAug 12 15:49 ET

Haemonetics Analyst Ratings

BenzingaAug 9 17:47 ET

Haemonetics: A Stable Outlook With Promising Profitability Targets Justifies Buy Rating

TipRanksAug 8 12:18 ET

Haemonetics Analyst Ratings

BenzingaJun 12 05:31 ET

Haemonetics Positioned for Strong Growth: Buy Rating Justified Amidst Operational and Financial Optimism

TipRanksMay 14 05:15 ET

Haemonetics Analyst Ratings

BenzingaMay 10 12:52 ET

Haemonetics Analyst Ratings

BenzingaMay 10 05:51 ET

Haemonetics (HAE) Gets a Hold From Needham

TipRanksMay 9 14:15 ET

Haemonetics Analyst Ratings

BenzingaApr 12 10:44 ET